Clinical Trials
43 trialsEPoRN
Jiangxi Provincial Cancer Hospital
STOPOMP
Mucosa Innovations, S.L.
ACUPUNCTURE
Wake Forest University Health Sciences
RADPAINT-3
Oslo University Hospital
PROTECT-NPC
Jiangxi Provincial Cancer Hospital
Rehabilitation Assessment and Progress Tracking System Based on Video Images for Dysphagic Patients
Mahidol University
A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer
Hebei Provincial Hospital of Traditional Chinese Medicine
ART-OPC
Centre hospitalier de l'Université de Montréal (CHUM)
DAHANCA PRO
Rigshospitalet, Denmark
RELAX
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
THYRO-RT
Tata Memorial Hospital
PBM&OM-01
Erika Carmel ltd
The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
ChineseAMS
HONEY
Cyprus University of Technology
CASP-ORL
Jessa Hospital
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
University of California, San Francisco
Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
Radiation Therapy Oncology Group
Treatment of Bevacizumab Followed by Steroid in RN
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Prevention of Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy
Chulabhorn Hospital
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
Radiation Therapy Oncology Group
BRAIN
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
Laval University
Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
Radiation Therapy Oncology Group
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Vanderbilt-Ingram Cancer Center
Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
Radiation Therapy Oncology Group
Randomized Amifostine For SCCHN
Dana-Farber Cancer Institute
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Alliance for Clinical Trials in Oncology
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Alliance for Clinical Trials in Oncology
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
Mayo Clinic
S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
National Cancer Institute (NCI)
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
Roswell Park Cancer Institute
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
National Cancer Institute (NCI)
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
National Cancer Institute (NCI)
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Radiation Therapy Oncology Group
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
National Cancer Institute (NCI)
HOHF
Rigshospitalet, Denmark
Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer
National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
European Organisation for Research and Treatment of Cancer - EORTC
Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Daiichi Sankyo
Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
National Cancer Institute (NCI)
Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors
National Cancer Institute (NCI)